About ViroCyt
ViroCyt is a company based in Denver (United States) founded in 2012 was acquired by Sartorius in July 2016. ViroCyt has raised $8.7 million across 2 funding rounds from investors including Sartorius. ViroCyt operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
- Headquarter Denver, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ViroCyt
ViroCyt has successfully raised a total of $8.7M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ViroCyt
ViroCyt has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Sartorius.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Laboratory and biopharmaceutical equipment is developed for production processes.
|
Locked | Locked | Locked |
Investor details for ViroCyt
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ViroCyt
Investment portfolio details for ViroCyt
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ViroCyt
Detailed financials for ViroCyt
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Virocyt Comparisons
Peer comparison for ViroCyt
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ViroCyt
ViroCyt operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, BioLife Solutions and Telesis Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
|
| Locked | Locked | Locked |
Online platform offering life sciences reagents and kits
|
|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
Detailed competitors of ViroCyt
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Virocyt
Complete news archive for ViroCyt
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ViroCyt
ViroCyt was founded in 2012 and raised its 1st funding round 1 year after it was founded.
ViroCyt is headquartered in Denver, United States. It is registered at Denver, Colorado, United States.
ViroCyt is a funded company, having raised a total of $8.7M across 2 funding rounds to date.
ViroCyt was founded in 2012 in Denver, United States, focusing on biotechnology tools for virus quantification. The Virus Counter 3100 is offered to measure total virus particle concentrations. Applications include vaccine production, protein expression, viral therapeutics, and anti-viral development. Operations center on providing analytical instruments for research and manufacturing in the life sciences sector.
ViroCyt's top competitors include Biocare Medical, Merck and Siemens Healthineers.
ViroCyt has 1 investor. Key investors include Sartorius.